<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="EN">
<front>
<journal-meta><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="nlm-ta">PLoS Comput Biol</journal-id><journal-id journal-id-type="pmc">ploscomp</journal-id><!--===== Grouping journal title elements =====--><journal-title-group><journal-title>PLoS Computational Biology</journal-title></journal-title-group><issn pub-type="ppub">1553-734X</issn><issn pub-type="epub">1553-7358</issn><publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="publisher-id">09-PLCB-RA-0619R3</article-id><article-id pub-id-type="doi">10.1371/journal.pcbi.1000583</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Cardiovascular Disorders/Arrhythmias, Electrophysiology, and Pacing</subject><subject>Cardiovascular Disorders/Myocardial Infarction</subject><subject>Computational Biology/Systems Biology</subject><subject>Physiology/Cell Signaling</subject><subject>Physiology/Integrative Physiology</subject></subj-group></article-categories><title-group><article-title>Oxidized Calmodulin Kinase II Regulates Conduction Following Myocardial Infarction: A Computational Analysis</article-title><alt-title alt-title-type="running-head">Oxidized CaMKII Regulates Conduction</alt-title></title-group><contrib-group>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Christensen</surname><given-names>Matthew D.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Dun</surname><given-names>Wen</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Boyden</surname><given-names>Penelope A.</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Anderson</surname><given-names>Mark E.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mohler</surname><given-names>Peter J.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hund</surname><given-names>Thomas J.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
</contrib-group><aff id="aff1"><label>1</label><addr-line>Department of Internal Medicine, Division of Cardiovascular Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa, United States of America</addr-line>       </aff><aff id="aff2"><label>2</label><addr-line>Department of Molecular Physiology and Biophysics, University of Iowa Carver College of Medicine, Iowa City, Iowa, United States of America</addr-line>       </aff><aff id="aff3"><label>3</label><addr-line>Department of Pharmacology, Center for Molecular Therapeutics, Columbia University, New York, New York, United States of America</addr-line>       </aff><contrib-group>
<contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>McCulloch</surname><given-names>Andrew D.</given-names></name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/></contrib>
</contrib-group><aff id="edit1">University of California, San Diego, United States of America</aff><author-notes>
<corresp id="cor1">* E-mail: <email xlink:type="simple">thomas-hund@uiowa.edu</email></corresp>
<fn fn-type="con"><p>Conceived and designed the experiments: MDC PAB TJH. Performed the experiments: MDC WD PAB TJH. Analyzed the data: MDC MEA PJM TJH. Contributed reagents/materials/analysis tools: MDC WD PAB MEA PJM TJH. Wrote the paper: MDC PAB MEA PJM TJH.</p></fn>
<fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn></author-notes><pub-date pub-type="collection"><month>12</month><year>2009</year></pub-date><pub-date pub-type="epub"><day>4</day><month>12</month><year>2009</year></pub-date><volume>5</volume><issue>12</issue><elocation-id>e1000583</elocation-id><history>
<date date-type="received"><day>28</day><month>5</month><year>2009</year></date>
<date date-type="accepted"><day>30</day><month>10</month><year>2009</year></date>
</history><!--===== Grouping copyright info into permissions =====--><permissions><copyright-year>2009</copyright-year><copyright-holder>Christensen et al</copyright-holder><license><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><abstract>
<p>Calmodulin kinase II (CaMKII) mediates critical signaling pathways responsible for divergent functions in the heart including calcium cycling, hypertrophy and apoptosis. Dysfunction in the CaMKII signaling pathway occurs in heart disease and is associated with increased susceptibility to life-threatening arrhythmia. Furthermore, CaMKII inhibition prevents cardiac arrhythmia and improves heart function following myocardial infarction. Recently, a novel mechanism for oxidative CaMKII activation was discovered in the heart. Here, we provide the first report of CaMKII oxidation state in a well-validated, large-animal model of heart disease. Specifically, we observe increased levels of oxidized CaMKII in the infarct border zone (BZ). These unexpected new data identify an alternative activation pathway for CaMKII in common cardiovascular disease. To study the role of oxidation-dependent CaMKII activation in creating a pro-arrhythmia substrate following myocardial infarction, we developed a new mathematical model of CaMKII activity including both oxidative and autophosphorylation activation pathways. Computer simulations using a multicellular mathematical model of the cardiac fiber demonstrate that enhanced CaMKII activity in the infarct BZ, due primarily to increased oxidation, is associated with reduced conduction velocity, increased effective refractory period, and increased susceptibility to formation of conduction block at the BZ margin, a prerequisite for reentry. Furthermore, our model predicts that CaMKII inhibition improves conduction and reduces refractoriness in the BZ, thereby reducing vulnerability to conduction block and reentry. These results identify a novel oxidation-dependent pathway for CaMKII activation in the infarct BZ that may be an effective therapeutic target for improving conduction and reducing heterogeneity in the infarcted heart.</p>
</abstract><abstract abstract-type="summary"><title>Author Summary</title>
<p>Calmodulin kinase II (CaMKII) is a multifunctional serine/threonine kinase that regulates diverse functions in heart. Recently, a novel pathway for CaMKII activation was discovered where oxidation of the kinase at specific methionine residues produces persistent activity. This alternative oxidation-dependent pathway has important implications for heart disease where oxidative stress is increased (e.g., heart failure and following myocardial infarction). We hypothesized that myocardial infarction caused by occlusion of a coronary artery would increase levels of oxidized CaMKII. Moreover, we hypothesized that oxidative CaMKII activation represents an important mechanistic link between increased oxidative stress and life-threatening heart rhythm disturbances (arrhythmias) in heart disease. We report a dramatic increase in levels of oxidized CaMKII following myocardial infarction in the canine. Based on these experimental data, we developed a novel mathematical model of CaMKII activity to study the role of oxidation-dependent CaMKII activation in regulating cardiac cell excitability. Our findings identify a novel role for oxidation-dependent CaMKII activation following myocardial infarction and provide a mechanistic link between oxidative stress and lethal cardiac arrhythmias in heart disease.</p>
</abstract><funding-group><funding-statement>This work was supported by the American Heart Association (0930378N to TJH), National Institutes of Health (HL096805 to TJH; HL084583 and HL083422 to PJM; HL079031, HL62494, HL70250 to MEA; HL66140 to PAB), the Pew Scholars Trust (PJM), and a Fondation Leducq Award to the Alliance for Calmodulin Kinase Signaling in Heart Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="11"/></counts></article-meta>
</front>
<body><sec id="s1">
<title>Introduction</title>
<p>Calmodulin kinase II (CaMKII) mediates diverse roles in the heart, including excitation-contraction coupling, sinus node automaticity, apoptosis, hypertrophy, and gene transcription <xref ref-type="bibr" rid="pcbi.1000583-Maier1">[1]</xref>,<xref ref-type="bibr" rid="pcbi.1000583-Anderson1">[2]</xref>. Mounting experimental evidence demonstrates an important role for CaMKII in heart disease and arrhythmias. Specifically, CaMKII overexpression occurs in human heart failure <xref ref-type="bibr" rid="pcbi.1000583-Hoch1">[3]</xref> and transgenic mice overexpressing CaMKII develop dilated cardiomyopathy <xref ref-type="bibr" rid="pcbi.1000583-Zhang1">[4]</xref>,<xref ref-type="bibr" rid="pcbi.1000583-Zhang2">[5]</xref>. Conversely, transgenic inhibition of CaMKII prevents structural remodeling and improves heart function following myocardial infarction (MI) <xref ref-type="bibr" rid="pcbi.1000583-Zhang3">[6]</xref> while knockout mice lacking the predominant cardiac CaMKII isoform (CaMKIIδ) are resistant to development of pressure overload-induced hypertrophy and/or heart failure <xref ref-type="bibr" rid="pcbi.1000583-Backs1">[7]</xref>,<xref ref-type="bibr" rid="pcbi.1000583-Ling1">[8]</xref>. Finally, CaMKII inhibition prevents arrhythmias in several different mouse models of heart disease <xref ref-type="bibr" rid="pcbi.1000583-Wu1">[9]</xref>,<xref ref-type="bibr" rid="pcbi.1000583-Khoo1">[10]</xref>.</p>
<p>CaMKII is activated by binding of Ca<sup>2+</sup>/calmodulin and may undergo inter-subunit autophosphorylation that allows the kinase to retain activity even upon dissociation of Ca<sup>2+</sup>/calmodulin (autonomy) <xref ref-type="bibr" rid="pcbi.1000583-Hudmon1">[11]</xref>. Recently, a novel CaMKII activation pathway was identified where oxidation at specific methionine residues in the CaMKII regulatory subunit results in persistent activity independent of autophosphorylation <xref ref-type="bibr" rid="pcbi.1000583-Erickson1">[12]</xref>. While oxidative-dependent CaMKII activation has been shown to mediate apoptosis in response to chronic AngII treatment in the mouse <xref ref-type="bibr" rid="pcbi.1000583-Erickson1">[12]</xref> as well as arrhythmogenic afterdepolarizations in isolated cardiomyocytes treated with hydrogen peroxide <xref ref-type="bibr" rid="pcbi.1000583-Xie1">[13]</xref>, nothing is known about its role in large animal models of heart disease. Considering that levels of reactive oxygen species (ROS) such as H<sub>2</sub>O<sub>2</sub> and superoxide are elevated following myocardial infarction <xref ref-type="bibr" rid="pcbi.1000583-Kinugawa1">[14]</xref>, we hypothesized that oxidation of CaMKII represents an important pathway for CaMKII activation in the infarct border zone (BZ) that may provide a mechanistic link between increased ROS production, Na<sup>+</sup> channel remodeling and conduction slowing following MI.</p>
<p>In this study, we describe a dramatic increase in levels of oxidized CaMKII in a well-validated large animal model of arrhythmias following MI <xref ref-type="bibr" rid="pcbi.1000583-Dillon1">[15]</xref>–<xref ref-type="bibr" rid="pcbi.1000583-Pu1">[22]</xref>. To investigate a role for oxidized CaMKII in regulating refractoriness and conduction in the infarct BZ, we develop a novel mathematical model of CaMKII activity that includes oxidation and autophosphorylation activation pathways. Our computer simulations show that enhanced CaMKII activity in the BZ, due primarily to increased oxidation, leads to slowed conduction, prolonged refractory periods and increased vulnerability to conduction block at the BZ margin (a prerequisite for reentry initiation). Our results identify oxidation-dependent CaMKII activation as a potential link between oxidative stress and electrical remodeling after myocardial infarction. Furthermore, our findings support CaMKII inhibition as a potential therapy for reducing susceptibility to ventricular tachycardia by improving conduction and reducing refractory gradients in the infarcted heart. Finally, it is important to note the oxidative activation of CaMKII allows for independent regulation of the kinase by a host of unique upstream activators and signaling partners (e.g. oxidases/reductases) with great potential relevance to human disease. As details emerge regarding regulation of the kinase by this newly identified pathway, they may be incorporated into our model to study electrophysiological consequences of CaMKII activation via this independent signaling pathway.</p>
</sec><sec id="s2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="s2a">
<title/>
<sec id="s2a1">
<title>Experimental model of myocardial infarction and immunoblotting</title>
<p>Myocardial infarction (MI) was produced by total coronary artery occlusion, as described previously <xref ref-type="bibr" rid="pcbi.1000583-Pu1">[22]</xref>. A cardiectomy was performed five days after surgery and thin tissue slices from visible epicardial BZ and from a remote area away from the infarct (left ventricular base) were flash frozen for immunoblot analysis. Ventricular lysates were prepared for immunoblot analysis as described <xref ref-type="bibr" rid="pcbi.1000583-Hund2">[21]</xref>. Equal quantities of protein were analyzed by SDS-PAGE (3–8% Tris acetate gels) under non-reducing conditions <xref ref-type="bibr" rid="pcbi.1000583-Erickson1">[12]</xref>. Immunoblotting was performed using a validated antiserum to oxidized CaMKII <xref ref-type="bibr" rid="pcbi.1000583-Erickson1">[12]</xref>. Slight differences in protein loading were corrected using an internal control standard (rabbit polyclonal antibody to actin (Santa Cruz)).</p>
</sec><sec id="s2a2">
<title>Animal information</title>
<p>This investigation used adult mongrel dogs (12 to 15 kg, 2 to 3 years old) and conforms to the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health (Pub. No. 85-23,1996).</p>
</sec><sec id="s2a3">
<title>Fiber model</title>
<p>A multicellular fiber comprised of 200 cells in a serial arrangement was used to simulate action potential (AP) propagation through normal and border zone tissue as described previously <xref ref-type="bibr" rid="pcbi.1000583-Shaw1">[23]</xref>. Briefly, Equation 1 describing axial current flow along the theoretical fiber was discretized and solved numerically by the Crank-Nicholson implicit method:<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000583.e001" xlink:type="simple"/><label>(1)</label></disp-formula>where <italic>I<sub>ax</sub></italic> is the axial current, <italic>a</italic> is the fiber radius (0.0011 cm), <italic>R<sub>i</sub></italic> is the axial resistance per unit length (Ω.cm, composed of <italic>R<sub>myo</sub></italic> (150 Ωcm) and <italic>R<sub>g</sub></italic> (1.5 Ωcm<sup>2</sup>)), <italic>C<sub>m</sub></italic> is the membrane capacitance (1 µF/cm<sup>2</sup>), and <italic>I<sub>ion</sub></italic> is the transmembrane current density. A discretization element of Δx = 0.01 cm corresponding to one cell length was used in all simulations. An adaptive time step (Δt) was implemented that solves for transmembrane currents and <italic>V<sub>m</sub></italic> along the fiber with Δt = 5 µs during AP wavefront propagation, Δt = 10 µs during repolarization, and Δt = 50 µs during diastole. Solutions using the adaptive timestep were verified to be within 1% of those using a constant Δt = 5 µs.</p>
<p>Transmembrane currents and ion concentration changes at each cell in the fiber are described by the Hund-Rudy dynamic (HRd) model of the canine epicardial myocyte <xref ref-type="bibr" rid="pcbi.1000583-Hund1">[20]</xref>,<xref ref-type="bibr" rid="pcbi.1000583-Hund3">[24]</xref>. Modifications to the HRd equations to account for experimentally measured remodeling changes to several major ion channels in the infarct border zone <xref ref-type="bibr" rid="pcbi.1000583-Hund1">[20]</xref> were used to represent each cell in the BZ fiber model. Equations differing from the original publications and variable definitions may be found in supplementary information (<xref ref-type="supplementary-material" rid="pcbi.1000583.s006">Text S1</xref> and <xref ref-type="supplementary-material" rid="pcbi.1000583.s003">Table S1</xref>).</p>
</sec><sec id="s2a4">
<title>Pacing protocol</title>
<p>The fiber was paced at one end to steady state using a conservative current stimulus <xref ref-type="bibr" rid="pcbi.1000583-Hund4">[25]</xref> (cycle length  = 500 ms, stimulus amplitude  = −450 µA/µF, stimulus duration  = 0.5 ms). The steady-state values for all state variables were used as initial conditions (<xref ref-type="supplementary-material" rid="pcbi.1000583.s004">Table S2</xref>) for subsequent simulations.</p>
</sec><sec id="s2a5">
<title>Statistics</title>
<p>When appropriate, differences between groups were analyzed with ANOVA and least squares difference post-hoc test. A value of p&lt;0.05 was considered statistically significant. Values are expressed as mean ± SD.</p>
</sec></sec></sec><sec id="s3">
<title>Results</title>
<sec id="s3a">
<title>CaMKII is oxidized in the infarct border zone</title>
<p>Based on the recent discovery of a novel oxidation-dependent pathway for CaMKII activation <xref ref-type="bibr" rid="pcbi.1000583-Erickson1">[12]</xref>, immunoblot analysis was first performed in a well-validated large animal model of arrhythmias <xref ref-type="bibr" rid="pcbi.1000583-Dillon1">[15]</xref>–<xref ref-type="bibr" rid="pcbi.1000583-Pu1">[22]</xref> to determine whether oxidization of CaMKII occurs in the infarct BZ five days post-occlusion (<xref ref-type="fig" rid="pcbi-1000583-g001">Figure 1</xref>). Interestingly, levels of oxidized CaMKII were over eight-fold greater in the five-day BZ compared to normal (non-infarcted) (p&lt;0.01), but were unchanged in remote regions of the same hearts (<xref ref-type="fig" rid="pcbi-1000583-g001">Figure 1</xref>, p = NS vs. normal). These data together with our previous findings that CaMKII autophosphorylation is significantly increased in the five-day infarct BZ <xref ref-type="bibr" rid="pcbi.1000583-Hund1">[20]</xref> indicate that CaMKII activity is enhanced in the infarct BZ.</p>
<fig id="pcbi-1000583-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1000583.g001</object-id><label>Figure 1</label><caption>
<title>Increased levels of oxidized CaMKII following myocardial infarction.</title>
<p>(A) Representative immunoblots and (B) densitometric measurements (normalized to actin and expressed relative to normal levels) of oxidized CaMKII from remote and BZ regions of normal and infarcted hearts. Error bars designate standard deviation (*p&lt;0.01 compared to normal BZ or remote, n = 4).</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000583.g001" xlink:type="simple"/></fig></sec><sec id="s3b">
<title>Model of oxidative CaMKII activation and action potential propagation</title>
<p>To determine whether enhanced CaMKII activity, due in part to oxidation (<xref ref-type="fig" rid="pcbi-1000583-g001">Figure 1</xref>), regulates conduction in the infarct BZ, we revised our model of the canine ventricular action potential <xref ref-type="bibr" rid="pcbi.1000583-Hund1">[20]</xref>,<xref ref-type="bibr" rid="pcbi.1000583-Hund3">[24]</xref> to include a new model of CaMKII activity based on the simplified scheme proposed by Dupont et al <xref ref-type="bibr" rid="pcbi.1000583-Dupont1">[26]</xref>–<xref ref-type="bibr" rid="pcbi.1000583-Hashambhoy1">[28]</xref> (<xref ref-type="fig" rid="pcbi-1000583-g002">Figure 2</xref>). Importantly, our model includes an oxidized active state in addition to a Ca<sup>2+</sup>/CaM bound active state and an autophosphorylated active state. Inclusion of an additional autonomous active state (Ca<sup>2+</sup>/CaM dissociates from phosphorylated subunit) was found to have no impact on model behavior (state occupancy &lt;0.001%, not shown) and was therefore not included in the final model. Consistent with experimental observations <xref ref-type="bibr" rid="pcbi.1000583-Erickson1">[12]</xref>, Ca<sup>2+</sup>/CaM must bind to a subunit before oxidation may occur (no direct transition from inactive to oxidized active state). Rate constants for state transitions were taken from the literature or chosen to fit experimental data (<xref ref-type="supplementary-material" rid="pcbi.1000583.s005">Table S3</xref>, <xref ref-type="fig" rid="pcbi-1000583-g002">Figure 2B–D</xref>). Model equations are provided in supplementary information (<xref ref-type="supplementary-material" rid="pcbi.1000583.s006">Text S1</xref>). Our experimental data demonstrate a significant increase in both oxidized (<xref ref-type="fig" rid="pcbi-1000583-g001">Figure 1</xref>) and autophosphorylated CaMKII <xref ref-type="bibr" rid="pcbi.1000583-Hund1">[20]</xref> in the infarct BZ. Even though autophosphorylation and oxidation occur through distinct pathways, the model assumes that the same subunit may be both oxidized and autophosphorylated. Furthermore, consistent with previous work <xref ref-type="bibr" rid="pcbi.1000583-Dupont1">[26]</xref>–<xref ref-type="bibr" rid="pcbi.1000583-Hashambhoy1">[28]</xref>, the model assumes that any active subunit (including oxidized) may autophosphorylate another Ca<sup>2+</sup>/CaM bound subunit. Thus, the model predicts a secondary increase in the fraction of autophosphorylated CaMKII subunits with an increase in oxidized subunits due to oxidative stress (<xref ref-type="fig" rid="pcbi-1000583-g002">Figure 2E</xref>). Currently, the upstream pathways responsible for increased CaMKII autophosphorylation are unknown. However, our model predicts that oxidative stress may account for the increase in both oxidized and autophosphorylated subunits measured in the infarct BZ (<xref ref-type="fig" rid="pcbi-1000583-g002">Figure 2E</xref>). Thus, for the purpose of this study, we assume that the primary defect responsible for activated CaMKII in the BZ is oxidative stress.</p>
<fig id="pcbi-1000583-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1000583.g002</object-id><label>Figure 2</label><caption>
<title>Mathematical model of CaMKII activity.</title>
<p>(A) State diagram for CaMKII including activation by Ca<sup>2+</sup>/CaM (<italic>B</italic>), oxidation (<italic>Ox</italic>), and autophosphorylation (<italic>P</italic>). Rate constants are provided in supplementary information (<xref ref-type="supplementary-material" rid="pcbi.1000583.s006">Text S1</xref> and <xref ref-type="supplementary-material" rid="pcbi.1000583.s005">Table S3</xref>). (B) Simulated dose-dependent activation of CaMKII by H<sub>2</sub>O<sub>2</sub> compared to experiment <xref ref-type="bibr" rid="pcbi.1000583-Erickson1">[12]</xref>. Ca<sup>2+</sup>/CaM  = 1 µM and autophosphorylation rate  = 0 in simulations corresponding to the following experimental conditions: 200 µM Ca<sup>2+</sup>, 1 µM CaM in the absence of ATP (to prevent autophosphorylation). Simulated CaM dependence of (C) CaMKII activity and (D) autophosphorylation compared to experiment <xref ref-type="bibr" rid="pcbi.1000583-Gaertner1">[50]</xref>. Saturating conditions for Ca<sup>2+</sup> (Ca<sup>2+</sup> = 0.5 mM) are used in experiment and simulation to allow for control of [Ca<sup>2+</sup>/CaM] by varying [CaM]. (E) Simulated levels of CaMKII oxidation and autophosphorylation in the BZ model for different levels of oxidative stress (model paced to steady-state at cycle length of 500 ms).</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000583.g002" xlink:type="simple"/></fig>
<p>While absolute measures of H<sub>2</sub>O<sub>2</sub> levels are limited (likely less than 0.25 µM at baseline <xref ref-type="bibr" rid="pcbi.1000583-Frei1">[29]</xref>,<xref ref-type="bibr" rid="pcbi.1000583-Halliwell1">[30]</xref>), an increase in ROS levels from 10- to 100-fold have been reported following ischemia-reperfusion <xref ref-type="bibr" rid="pcbi.1000583-Slezak1">[31]</xref>–<xref ref-type="bibr" rid="pcbi.1000583-Dhalla1">[33]</xref>. Furthermore, ROS levels of 10 µM <italic>in vitro</italic> have been shown to recapitulate the level of oxidative stress observed <italic>in vivo</italic> in the BZ <xref ref-type="bibr" rid="pcbi.1000583-Fukuda1">[34]</xref>. Unless otherwise stated, we assume [ROS]  = 1.0 µM in the BZ, likely a conservative estimate. However, based on the fact that the exact level of ROS is unknown in the BZ and is likely to be highly heterogeneous, we also explore a range of ROS levels from 0 to 10 µM. Note that for [ROS]  = 1 µM, the fraction of autophosphorylated subunits in the BZ is much lower than the fraction of oxidized subunits (0.11 for autophosphorylation compared to 0.75 for oxidation, <xref ref-type="fig" rid="pcbi-1000583-g002">Figure 2E</xref>), indicating that oxidation rather than autophosphorylation is the primary determinant of increased CaMKII activity in the BZ model.</p>
<p>Importantly, our model of the BZ myocyte also accounts for observed remodeling changes to the density and/or kinetics of several ion channels, including the L-type Ca<sup>2+</sup> current, transient outward K<sup>+</sup> current, and Na<sup>+</sup> current <xref ref-type="bibr" rid="pcbi.1000583-Hund1">[20]</xref>. Specifically for the Na<sup>+</sup> current, changes to kinetics and peak current have been observed <xref ref-type="bibr" rid="pcbi.1000583-Pu1">[22]</xref>. Since CaMKII has been shown to alter Na<sup>+</sup> channel kinetics but not peak current, our model assumes that the reduction in total Na<sup>+</sup> channel density occurs through a CaMKII-independent pathway <xref ref-type="bibr" rid="pcbi.1000583-Hund1">[20]</xref>. NZ (control) and BZ cell models are incorporated into one-dimensional fibers to study conduction (<xref ref-type="fig" rid="pcbi-1000583-g003">Figure 3</xref>).</p>
<fig id="pcbi-1000583-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1000583.g003</object-id><label>Figure 3</label><caption>
<title>Mathematical model of cardiac action potential and electrical conduction.</title>
<p>(A) Hund-Rudy dynamic (HRd) canine ventricular epicardial cell model. Symbols are defined in text and in <xref ref-type="supplementary-material" rid="pcbi.1000583.s003">Table S1</xref>. (B) One-dimensional fiber model comprised of individual cells electrically coupled through gap junctions. A current stimulus is applied at the end of the fiber (cell 1) and the excitation wavefront propagates down the fiber. (C) Simulated action potentials from every 20<sup>th</sup> cell in the control (<italic>top</italic>) and border zone (<italic>bottom</italic>) fibers.</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000583.g003" xlink:type="simple"/></fig></sec><sec id="s3c">
<title>CaMKII regulates <italic>I<sub>Na</sub></italic> inactivation in border zone</title>
<p><italic>I</italic><sub>Na</sub> inactivation and recovery from inactivation were first determined in the NZ and BZ fiber after pacing to steady state (<xref ref-type="fig" rid="pcbi-1000583-g004">Figure 4</xref>). <italic>I</italic><sub>Na</sub> recovery from inactivation was determined by applying a premature stimulus (S2) at a varying S1S2 interval and plotting channel availability (calculated as product of inactivation gates, h*j) vs. recovery interval (S1S2 interval - APD<sub>90</sub>). <italic>I</italic><sub>Na</sub> steady-state inactivation is shifted to more hyperpolarized potentials (<xref ref-type="fig" rid="pcbi-1000583-g004">Figure 4A</xref>) and recovery from inactivation is slower (<xref ref-type="fig" rid="pcbi-1000583-g004">Figure 4C</xref>) in the BZ fiber compared to NZ, consistent with our single cell simulations <xref ref-type="bibr" rid="pcbi.1000583-Hund1">[20]</xref> and experimental measurements <xref ref-type="bibr" rid="pcbi.1000583-Pu1">[22]</xref>. CaMKII inhibition (CaMKII activity held constant at zero) shifts <italic>I<sub>Na</sub></italic> steady state inactivation to more depolarized potentials (<xref ref-type="fig" rid="pcbi-1000583-g004">Figure 4A</xref>) and accelerates recovery from inactivation in the BZ fiber (<xref ref-type="fig" rid="pcbi-1000583-g004">Figure 4C</xref>) but has little effect in NZ (steady-state inactivation and recovery curves superimpose curves from BZ+CaMKII inhibition model, not shown). Thus differences in <italic>I</italic><sub>Na</sub> inactivation between NZ and BZ observed under control conditions are largely eliminated upon CaMKII inhibition (<xref ref-type="fig" rid="pcbi-1000583-g004">Figure 4</xref>).</p>
<fig id="pcbi-1000583-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1000583.g004</object-id><label>Figure 4</label><caption>
<title>CaMKII regulates <italic>I<sub>Na</sub></italic> in the infarct border zone.</title>
<p>(A) Steady-state <italic>I<sub>Na</sub></italic> inactivation curves in NZ and BZ models (pulse protocol shown in <italic>inset</italic>). Inhibition of the CaMKII pathway (CaMKII activity held constant at zero) eliminates differences between NZ and BZ <italic>I<sub>Na</sub></italic> steady-state inactivation. (B) Simulated Na<sup>+</sup> currents in control (<italic>top</italic>) and border zone (<italic>bottom</italic>) models during application of a premature stimulus to cell 1 at varying S1S2 interval to determine recovery from inactivation. (C) <italic>I<sub>Na</sub></italic> availability (<italic>h*j</italic>) in control and border zone models with and without CaMKII inhibition. <italic>I<sub>Na</sub></italic> recovery is dramatically slower in the border zone fiber compared to control. CaMKII inhibition in the BZ accelerates recovery from inactivation to a rate similar to NZ (recovery curve for NZ model + CaMKII inhibition superimposes curve for BZ model + CaMKII inhibition, not shown).</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000583.g004" xlink:type="simple"/></fig></sec><sec id="s3d">
<title>CaMKII regulates conduction in border zone</title>
<p>Based on the effects of CaMKII on <italic>I</italic><sub>Na</sub> availability, we hypothesized that enhanced CaMKII activity would promote slow conduction in the BZ. While resting transmembrane potential is comparable between isolated BZ and NZ myocytes <xref ref-type="bibr" rid="pcbi.1000583-Lue1">[19]</xref>, membrane depolarization is observed in multicellular BZ preparations <xref ref-type="bibr" rid="pcbi.1000583-Ursell1">[35]</xref>,<xref ref-type="bibr" rid="pcbi.1000583-Lau1">[36]</xref>. Therefore, we measured conduction velocity in NZ and BZ fibers over a range of end diastolic potentials (V<sub>m,dia</sub>, −86 to −63 mV), by increasing [K<sup>+</sup>]<sub>o</sub> incrementally from 5.4 to 13 mM. Conduction velocity was measured across the central 100 cells (<xref ref-type="fig" rid="pcbi-1000583-g005">Figure 5</xref>). Conduction was dramatically slower at every V<sub>m,dia</sub> in the BZ compared to NZ (65–100% slower) (<xref ref-type="fig" rid="pcbi-1000583-g005">Figure 5A</xref>). Furthermore, while successful conduction was observed in the NZ for potentials up to −64 mV, conduction block occurred in the BZ for V<sub>m,dia</sub> &gt;−72 mV. In fact, conduction velocity is steeply dependent on the concentration of ROS in the BZ over a range of concentrations from about 0.01 µM to 1 µM (<xref ref-type="supplementary-material" rid="pcbi.1000583.s001">Figure S1</xref>). To determine the role of oxidation-dependent CaMKII activity in conduction slowing in the BZ, we measured conduction velocity in the BZ model resistant to CaMKII oxidation (CaMKII<sub>ox</sub>  = 0). Making CaMKII resistant to oxidation increased conduction velocity at all V<sub>m,dia</sub> in the BZ with a greater effect at more depolarized V<sub>m,dia</sub> (<xref ref-type="fig" rid="pcbi-1000583-g005">Figure 5A</xref>). Moreover, successful conduction was restored in the BZ for V<sub>m,dia</sub> up to −68 mV (compared to −64 mV in the control). In contrast, the BZ model resistant to CaMKII autophosphorylation showed very little improvement in conduction (<xref ref-type="supplementary-material" rid="pcbi.1000583.s002">Figure S2</xref>). Furthermore, inhibiting total CaMKII activity showed a similar improvement in conduction as the oxidation-resistant model (<xref ref-type="fig" rid="pcbi-1000583-g005">Figure 5B</xref>), indicating that oxidation is the primary determinant of enhanced kinase activity in our BZ model. To verify that CaMKII-dependent effects on conduction were mediated by regulation of <italic>I</italic><sub>Na</sub> kinetics, we also calculated conduction velocity in the BZ model with <italic>I</italic><sub>Na</sub> resistant to CaMKII phosphorylation. As expected, this model showed a similar improvement in conduction as the oxidation-resistant model (<xref ref-type="fig" rid="pcbi-1000583-g005">Figure 5B</xref>), indicating that enhanced CaMKII activity regulates conduction by altering <italic>I</italic><sub>Na</sub> kinetics. In summary, enhanced CaMKII activity contributes to reduced conduction velocity in the BZ fiber, even promoting conduction block in the setting of depolarized transmembrane potential.</p>
<fig id="pcbi-1000583-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1000583.g005</object-id><label>Figure 5</label><caption>
<title>CaMKII regulates conduction in the infarct border zone.</title>
<p>(A) Conduction velocity vs. end diastolic potential (V<sub>m,dia</sub>) in normal and border zone fibers. [K<sup>+</sup>]<sub>o</sub> is increased incrementally from 5.4 mM to 13 mM to depolarize V<sub>m,dia</sub> from −87 to −63 mV. Elimination of oxidation-dependent CaMKII activation (oxidation-resistant CaMKII) increases conduction velocity at all V<sub>m,dia</sub> and extends the range of V<sub>m,dia</sub> over which successful conduction occurs in the border zone fiber. (B) Total CaMKII inhibition and eliminating CaMKII-dependent effects on <italic>I<sub>Na</sub></italic> have a similar effect on conduction velocity as making CaMKII resistant to oxidation. (C) Conduction velocity vs. gap junction resistance (R<sub>g</sub>) in NZ and BZ fibers ([K<sup>+</sup>]<sub>o</sub>  = 8.0 mM). Eliminating oxidation-dependent CaMKII activation improves conduction in the BZ fiber even at very high degrees of cell uncoupling (R<sub>g</sub> up to 150 Ωcm<sup>2</sup>).</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000583.g005" xlink:type="simple"/></fig>
<p>Remodeling in BZ tissue involves not only changes to ion channel properties and rest potential, but also intracellular communication <xref ref-type="bibr" rid="pcbi.1000583-Cabo1">[37]</xref>,<xref ref-type="bibr" rid="pcbi.1000583-Peters1">[38]</xref>. In order to address whether cellular uncoupling affects the role of oxidized CaMKII in regulating conduction, we determined conduction velocity in the fiber over a range of gap junction resistances (<xref ref-type="fig" rid="pcbi-1000583-g005">Figure 5C</xref>). Increasing gap junctional resistance (R<sub>g</sub>) from 1.5 to 60 Ωcm<sup>2</sup> produced a similar decrease in conduction velocity in NZ and BZ fibers (86% and 90% decrease, respectively). Successful conduction occurred in the NZ fiber for R<sub>g</sub> up to 300 Ωcm<sup>2</sup>, while conduction block was observed in the BZ fiber for R<sub>g</sub>&gt;76 Ωcm<sup>2</sup>. Eliminating oxidation-dependent CaMKII activity increased conduction velocity in the BZ fiber at all R<sub>g</sub> and restored conduction for R<sub>g</sub> up to 150 Ωcm<sup>2</sup> (<xref ref-type="fig" rid="pcbi-1000583-g005">Figure 5C</xref>), indicating that CaMKII regulates conduction even in the setting of gap junction uncoupling.</p>
</sec><sec id="s3e">
<title>CaMKII regulates effective refractory period in border zone</title>
<p>Effective refractory period (ERP) of the action potential is dramatically prolonged in BZ compared to NZ, despite comparable action potential durations <xref ref-type="bibr" rid="pcbi.1000583-Gough1">[18]</xref>,<xref ref-type="bibr" rid="pcbi.1000583-Lue1">[19]</xref>,<xref ref-type="bibr" rid="pcbi.1000583-Ursell1">[35]</xref>. Moreover, large gradients in refractoriness at the BZ margin have been associated with conduction block and the initiation of reentrant arrhythmias <xref ref-type="bibr" rid="pcbi.1000583-Dillon1">[15]</xref>,<xref ref-type="bibr" rid="pcbi.1000583-ElSherif2">[17]</xref>,<xref ref-type="bibr" rid="pcbi.1000583-Gough1">[18]</xref>. Based on these data and the ability of CaMKII to regulate <italic>I</italic><sub>Na</sub> recovery from inactivation (<xref ref-type="fig" rid="pcbi-1000583-g004">Figure 4C</xref>), we hypothesized that enhanced CaMKII activity would contribute to prolonged refractoriness in the BZ. To test our hypothesis, ERP was determined in NZ and BZ fibers by applying a premature (S2) stimulus during the repolarization phase of the action potential at cell 1 (site of S1 stimulus). The S1S2 interval was increased until a second propagating wave was generated in the wake of the final S1 stimulated AP (<xref ref-type="fig" rid="pcbi-1000583-g006">Figure 6</xref>). ERP is defined as the largest S1S2 interval that fails to generate a propagating excitation wave and is a function of both action potential duration (APD) and postrepolarization refractoriness. Consistent with experiment <xref ref-type="bibr" rid="pcbi.1000583-Gough1">[18]</xref>,<xref ref-type="bibr" rid="pcbi.1000583-Lue1">[19]</xref>,<xref ref-type="bibr" rid="pcbi.1000583-Ursell1">[35]</xref>, ERP is much greater in the BZ model (213 ms compared to 181 in the NZ) (<xref ref-type="fig" rid="pcbi-1000583-g006">Figure 6</xref>). Small differences in APD (173 ms and 187 ms in NZ and BZ, respectively) account for only a portion of this difference in ERP. Rather the primary determinant of prolonged ERP in the BZ is increased postrepolarization refractoriness due to the much slower time course of recovery from inactivation of <italic>I</italic><sub>Na</sub> (<xref ref-type="fig" rid="pcbi-1000583-g004">Figure 4C</xref>). Making CaMKII resistant to oxidative activation reduces ERP to 207 ms in the BZ model despite a slight prolongation of APD (<xref ref-type="fig" rid="pcbi-1000583-g006">Figure 6C</xref>) by eliminating differences in postrepolarization refractoriness (measured as ERP – APD, <xref ref-type="fig" rid="pcbi-1000583-g006">Figure 6D</xref>). Likewise, total CaMKII inhibition and making <italic>I</italic><sub>Na</sub> resistant to CaMKII phosphorylation reduce ERP by normalizing postrepolarization refractoriness (<xref ref-type="fig" rid="pcbi-1000583-g006">Figure 6D</xref>). These results suggest that oxidation-dependent CaMKII activation contributes to large gradients of refractoriness, particularly at the margins of the infarct BZ, by regulating <italic>I</italic><sub>N<italic>a</italic></sub> kinetics.</p>
<fig id="pcbi-1000583-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1000583.g006</object-id><label>Figure 6</label><caption>
<title>CaMKII regulates effective refractory period in the infarct border zone.</title>
<p>A premature stimulus is applied to cell 1 at varying S1S2 intervals to determine the effective refractory period in (A) NZ, (B) BZ, and (C) BZ with oxidation-resistant CaMKII. Simulated action potentials are shown from cells 1, 20, 40, 60, and 80 along the fiber for the shortest S1S2 interval that generates a successfully propagating action potential. While ERP is longer in the BZ than in NZ (213 ms and 181 ms, respectively), elimination of oxidation-dependent CaMKII activation reduces these differences. (D) Postrepolarization refractoriness (ERP-APD<sub>90</sub>) in NZ, BZ, BZ with oxidation-resistant CaMKII, BZ with total CaMKII inhibition, and BZ with CaMKII-resistant <italic>I<sub>Na</sub></italic>.</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000583.g006" xlink:type="simple"/></fig></sec><sec id="s3f">
<title>CaMKII increases vulnerability to conduction block</title>
<p>Electrophysiological mapping during programmed stimulation to induce ventricular tachycardia has revealed that premature excitation block occurs in areas of large refractory gradients at the BZ margin <xref ref-type="bibr" rid="pcbi.1000583-Gough1">[18]</xref>. Our findings that enhanced CaMKII activity substantially increases ERP in the BZ led us to hypothesize that CaMKII promotes formation of conduction block at the transition between normal and border zone tissue by introducing large refractory gradients. To test our hypothesis, we used a heterogeneous fiber comprised of coupled NZ (cells 1–75) and BZ (cells 126–200) cells with a central transitional region (cells 76–125) across which BZ parameters were linearly scaled. The size of the transitional region corresponds to the approximate width of the outer common pathway (about 5.0 mm <xref ref-type="bibr" rid="pcbi.1000583-Dillon1">[15]</xref>) (<xref ref-type="fig" rid="pcbi-1000583-g007">Figure 7A</xref>). The fiber was paced to steady state at cell 1 and a premature S2 stimulus was applied at the same cell. The S1S2 pacing interval was varied to determine the critical range of S1S2 intervals (vulnerable window, VW) that resulted in conduction block at the transition from the NZ into the BZ region. S1S2 intervals from 181 to 197 ms (VW = 18 ms) resulted in an action potential that propagated successfully through the NZ region but failed at the transition into the BZ region (<xref ref-type="fig" rid="pcbi-1000583-g007">Figure 7A</xref>). S1S2 pacing intervals shorter than this critical range failed to propagate even through the NZ region while S1S2 intervals greater than this range successfully propagated through the entire fiber (<xref ref-type="fig" rid="pcbi-1000583-g007">Figure 7B</xref>). V<sub>m</sub> and <italic>I</italic><sub>Na</sub> availability (h*j) spatial profiles as the wavefront reaches the BZ margin indicate that <italic>I</italic><sub>Na</sub> availability is a critical determinant of whether or not a premature wavefront blocks at the BZ margin (<xref ref-type="fig" rid="pcbi-1000583-g007">Figure 7C</xref>).</p>
<fig id="pcbi-1000583-g007" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1000583.g007</object-id><label>Figure 7</label><caption>
<title>Role of CaMKII in formation of conduction block at the border zone margin.</title>
<p>(A) Conduction block in a one-dimensional fiber comprised of NZ (cells 1–75), BZ (cells 126–200), and transitional (cells 76–125) regions. A premature S2 stimulus is applied at cell 1 to induce conduction block at the BZ margin (S1S2  = 190 ms). (B) Application of S2 at a coupling interval greater the vulnerable window (S1S2  = 500 ms) results in successful conduction through the entire fiber. (C) V<sub>m</sub> and <italic>I<sub>Na</sub></italic> availability (h*j) along the fiber as the wavefront reaches the BZ margin for a premature stimulus that blocks (S1S2  = 181 ms, black lines) or propagates successfully through the entire fiber (S1S2  = 198 ms, <italic>red lines</italic>).</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000583.g007" xlink:type="simple"/></fig>
<p><xref ref-type="fig" rid="pcbi-1000583-g008">Figure 8</xref> shows VW in the heterogeneous fiber as a function of V<sub>m,dia</sub> in the BZ region ([K<sup>+</sup>]<sub>o</sub> was scaled linearly across the transition region as with other BZ parameters). VW shows a monophasic increase as V<sub>m,dia</sub> is depolarized from −85 mV to −72 mV. V<sub>m,dia</sub> greater than −72 mV results in transient block at the BZ margin even at the basic cycle length of 500 ms. Making CaMKII resistant to oxidative activation greatly reduces VW at all V<sub>m,dia</sub> (<xref ref-type="fig" rid="pcbi-1000583-g008">Figure 8A</xref>). Furthermore, transient block is not observed at the basic cycle length until V<sub>m,dia</sub> is depolarized above −68 mV. Total CaMKII inhibition and making <italic>I</italic><sub>Na</sub> resistant to CaMKII phosphorylation also effectively prevented formation of block at the BZ margin (VW less than 1 ms for V<sub>m,dia</sub> up to −72 mV and −74 mV, respectively, not shown).</p>
<fig id="pcbi-1000583-g008" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1000583.g008</object-id><label>Figure 8</label><caption>
<title>Vulnerable window for conduction block.</title>
<p>(A) Range of S1S2 intervals that result in conduction block at the BZ margin (vulnerable window) as a function of end diastolic potential (V<sub>m,dia</sub>) in the BZ region. Results are shown for the fiber with heterogeneous properties (control, <italic>black line</italic>), with oxidation-resistant CaMKII (<italic>red line</italic>), and with normal <italic>I<sub>Na</sub></italic> conductance throughout (<italic>gray line</italic>). Eliminating oxidation-dependent CaMKII activity or heterogeneity in <italic>I<sub>Na</sub></italic> conductance greatly reduces the VW at all V<sub>m,dia</sub>. (B) V<sub>m</sub> and effective <italic>I<sub>Na</sub></italic> availability (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000583.e002" xlink:type="simple"/></inline-formula>) along the fiber as the action potential wavefront reaches the BZ margin for the fiber with heterogeneous properties (control, <italic>black lines</italic>), with oxidation-resistant CaMKII (<italic>red lines</italic>), and with normal <italic>I<sub>Na</sub></italic> conductance throughout (<italic>gray lines</italic>). [K<sup>+</sup>]<sub>o</sub> = 8.0 mM in the BZ region (and scaled linearly across the transition region). (C) Vulnerable window as a function of gap junction resistance (R<sub>g</sub>) in the BZ region for the fiber with heterogeneous properties (control, <italic>black line</italic>), with oxidation-resistant CaMKII (<italic>red line</italic>), and with normal <italic>I<sub>Na</sub></italic> conductance throughout (<italic>gray line</italic>). Eliminating oxidation-dependent CaMKII activity or normalizing <italic>I<sub>Na</sub></italic> conductance reduces VW at all R<sub>g</sub>.</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000583.g008" xlink:type="simple"/></fig>
<p>While these data show that oxidation-dependent CaMKII activation increases the vulnerability to conduction block at the BZ margin, a prerequisite for initiation of reentrant arrhythmias, it is important to note that CaMKII-independent remodeling of ion channels (notably <italic>I</italic><sub>Na</sub>) also likely play an important role. To address the role of CaMKII-independent remodeling in conduction block, we measured VW in the heterogeneous fiber with normal <italic>I</italic><sub>Na</sub> conductance throughout. Eliminating differences in <italic>I</italic><sub>Na</sub> conductance successfully reduced vulnerability to transient conduction block across a wide range of V<sub>m,dia</sub> (<xref ref-type="fig" rid="pcbi-1000583-g008">Figure 8A</xref>), indicating that both CaMKII-dependent (altered kinetics) and CaMKII-independent (reduced channel conductance) effects on <italic>I</italic><sub>Na</sub> increase the vulnerability to conduction block and reentrant arrhythmias at the BZ margin. Interestingly, eliminating either CaMKII-dependent (oxidation-resistant CaMKII) or CaMKII-independent (normal <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000583.e003" xlink:type="simple"/></inline-formula>) heterogeneities in the fiber resulted in a similar increase in the effective <italic>I</italic><sub>Na</sub> availability (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000583.e004" xlink:type="simple"/></inline-formula>) in the transition region (<xref ref-type="fig" rid="pcbi-1000583-g008">Figure 8B</xref>).</p>
<p>We next determined whether cellular uncoupling in the BZ region would alter the role of CaMKII-dependent or CaMKII-independent <italic>I</italic><sub>Na</sub> changes in formation of conduction block at the BZ margin (<xref ref-type="fig" rid="pcbi-1000583-g008">Figure 8C</xref>). Increasing R<sub>g</sub> in the BZ region (R<sub>g</sub> scaled linearly across the transition region as with other BZ parameters) had very little effect on VW for a moderate degree of uncoupling (R<sub>g</sub> up to 38 Ωcm<sup>2</sup>). However, VW increased sharply for R<sub>g</sub>&gt;38 Ωcm<sup>2</sup> until block occurred at the BZ margin even at the basic cycle length (R<sub>g</sub>&gt;60 Ωcm<sup>2</sup>). Eliminating oxidation-dependent CaMKII activation or normalizing <italic>I</italic><sub>Na</sub> conductance reduced VW at all R<sub>g</sub> (VW = 0 ms for R<sub>g</sub> up to 120 Ωcm<sup>2</sup> and 150 Ωcm<sup>2</sup>, respectively) indicating that CaMKII-dependent and CaMKII-independent effects on <italic>I</italic><sub>Na</sub> regulate VW even in the presence of cellular uncoupling.</p>
</sec></sec><sec id="s4">
<title>Discussion</title>
<p>Our data provide the first evidence for oxidation of CaMKII as an important component of the remodeling process following MI. Furthermore, our simulation results provide the following insight into regulation of CaMKII signaling by this novel oxidative pathway: 1) Significant oxidative activation of the kianse occurs under pathophysiological conditions; 2) Oxidative stress may activate the kinase not only through direct oxidation but also through a secondary increase in autophosphorylation; and 3) Changes in Na<sup>+</sup> channel kinetics due to oxidative CaMKII activation are sufficient to impact conduction in the BZ.</p>
<p>Conduction in the canine infarct border zone is highly irregular with areas of very slow and discontinuous conduction during sinus rhythm <xref ref-type="bibr" rid="pcbi.1000583-ElSherif2">[17]</xref>. During programmed stimulation, lines of conduction block often form transverse to the fiber axis leading to initiation of reentry and sustained ventricular tachycardia <xref ref-type="bibr" rid="pcbi.1000583-Dillon1">[15]</xref>,<xref ref-type="bibr" rid="pcbi.1000583-ElSherif1">[16]</xref>. The mechanisms responsible for conduction block and reentry in the BZ are unknown although remodeling changes in tissue refractoriness and electrical coupling most likely play important roles <xref ref-type="bibr" rid="pcbi.1000583-Dillon1">[15]</xref>–<xref ref-type="bibr" rid="pcbi.1000583-Gough1">[18]</xref>. At the cellular level, it is clear that Na<sup>+</sup> channel dysfunction contributes to reduced action potential upstroke and action potential amplitude in myocytes isolated from the infarct border zone <xref ref-type="bibr" rid="pcbi.1000583-Lue1">[19]</xref>,<xref ref-type="bibr" rid="pcbi.1000583-Pu1">[22]</xref>. Previous modeling studies have shown that decreased Na<sup>+</sup> channel availability contributes to prolonged refractoriness in BZ cells despite AP duration comparable to NZ <xref ref-type="bibr" rid="pcbi.1000583-Cabo2">[39]</xref> and that slowing of Na<sup>+</sup> channel recovery from inactivation or reducing Na<sup>+</sup> channel conductance increases the vulnerable period for unidirectional block in cardiac tissue <xref ref-type="bibr" rid="pcbi.1000583-Starmer1">[40]</xref>. Our simulations demonstrate that CaMKII may regulate both conduction velocity and refractoriness in the BZ through its effects on voltage-gated Na<sup>+</sup> channel kinetics. Furthermore, by introducing gradients in <italic>I</italic><sub>Na</sub> availability and refractoriness, CaMKII activation, due in part to oxidation, increases vulnerability to conduction block at the BZ margin, a prerequisite for reentrant excitation. Moreover, our simulations suggest that CaMKII inhibition improves conduction (particularly in depolarized tissue) and reduces ERP in the BZ, thereby reducing the risk for conduction block and reentrant excitation. These results are significant in light of experimental mapping studies showing premature excitation block in areas of large gradients in refractoriness <xref ref-type="bibr" rid="pcbi.1000583-Gough1">[18]</xref>. While the current study focuses on conduction defects in the BZ, it is important to note that CaMKII activation is also expected to regulate intracellular Ca<sup>2+</sup> cycling that itself may promote arrhythmias <xref ref-type="bibr" rid="pcbi.1000583-Anderson1">[2]</xref>.</p>
<p>Our findings regarding the effects of CaMKII on conduction are consistent with experimental studies in mice that over-express CaMKIIδ. Specifically, consistent with our simulations, CaMKIIδ over-expression results in prolonged QRS intervals (marker of slowed intraventricular conduction) and increased arrhythmia susceptibility <xref ref-type="bibr" rid="pcbi.1000583-Wagner1">[41]</xref>. In contrast, our finding that CaMKII acts to increase post-repolarization refractoriness and therefore ERP in the BZ does not agree with shorter refractory periods in CaMKIIδ mice <xref ref-type="bibr" rid="pcbi.1000583-Wagner1">[41]</xref>. While the nature of this discrepancy is unclear, it is difficult to reconcile the reported effects of CaMKII on Na<sup>+</sup> channel recovery (slowing) with the measured effects on refractoriness in transgenic mice. It is possible that the decrease in ERP measured in transgenic mice is due to secondary effects of chronic CaMKII over-expression rather than acute signaling effects. Regardless, further studies are needed to define the role of CaMKII in regulating refractoriness in the heart.</p>
<p>Clearly, many factors besides remodeling of voltage-gated Na<sup>+</sup> channels influence conduction in the infarct BZ. Specifically, alterations in cell-to-cell coupling due to gap junction remodeling and/or fibrosis undoubtedly play an important role in abnormal conduction. In fact, studies have shown a close correlation between location of the central common pathway of the reentrant circuit and connexin43 redistribution suggesting that gap junction remodeling is required for maintenance of reentrant excitation <xref ref-type="bibr" rid="pcbi.1000583-Cabo1">[37]</xref>,<xref ref-type="bibr" rid="pcbi.1000583-Peters1">[38]</xref>. Furthermore, preferential uncoupling along the transverse fiber axis is thought to increase the degree of anisotropy in the BZ and facilitate initiation and maintenance of reentry. In addition, remodeling of the extracellular space in the BZ likely interacts with changes in gap junction coupling to affect conduction <xref ref-type="bibr" rid="pcbi.1000583-Cabo3">[42]</xref>. Thus, cell communication is regulated by a complex set of ion channel and structural changes in the BZ. Importantly, we find that CaMKII-dependent changes in <italic>I</italic><sub>Na</sub> kinetics regulate conduction in the BZ independent of the degree of cell coupling. Moreover, we report that CaMKII inhibition may restore conduction in the BZ even in the setting of very poor coupling (R<sub>g</sub> up to 150 Ωcm<sup>2</sup>).</p>
<p>Previous studies have shown increased levels of ROS in five-day infarct BZ regions <xref ref-type="bibr" rid="pcbi.1000583-Fukuda1">[34]</xref>. Moreover, exposure of cardiac Na<sup>+</sup> channels expressed in HEK cells to ROS recapitulates the remodeling phenotypes observed in BZ myocytes. Our results suggest that the newly discovered oxidation-dependent pathway for CaMKII activation serves as a critical link between oxidative stress, enhanced CaMKII activity, Na<sup>+</sup> channel dysfunction, and abnormal conduction in the infarct BZ. Of course, CaMKII is unlikely to be the only pathway through which oxidative stress alters cell excitability as oxidation affects many proteins in the heart, including kinases, transcription factors, ion channels, pumps, transporters, Ca<sup>2+</sup> handling proteins, and contractile machinery <xref ref-type="bibr" rid="pcbi.1000583-Giordano1">[43]</xref>.</p>
<p>While studies from our group and others demonstrate an important role for activated CaMKII in remodeling following MI, the upstream signaling pathways responsible for enhanced CaMKII activity remain to be fully elucidated (<xref ref-type="fig" rid="pcbi-1000583-g008">Figure 8</xref>). In this study, we assume that oxidative stress is the primary cause of enhanced CaMKII activity through direct oxidation of the kinase that also produces a secondary increase in the fraction of autophosphorylated subunits (<xref ref-type="fig" rid="pcbi-1000583-g002">Figure 2E</xref>). Clearly, CaMKII oxidation downstream of increased ROS production is one possible pathway for CaMKII activation in the BZ (<xref ref-type="fig" rid="pcbi-1000583-g001">Figure 1</xref>). However, a number of other upstream factors likely play an important role in regulating CaMKII activity following MI. For example, β-adrenergic stimulation, observed in the setting of myocardial infarction, activates CaMKII <xref ref-type="bibr" rid="pcbi.1000583-Zhang3">[6]</xref> and may also contribute to electrical remodeling after MI. Another possible mechanism for dysfunction in the CaMKII signaling pathway involves loss of coordinate regulation by phosphatases. Recently, it was discovered that miR-1 over-expression causes CaMKII-dependent hyperphosphorylation of RyR2 and afterdepolarizations due to reduced expression of the B56α regulatory subunit of the serine/threonine protein phosphatase 2A, PP2A <xref ref-type="bibr" rid="pcbi.1000583-Terentyev1">[44]</xref>. Previous studies from our group have shown that B56α binds to, and is targeted by the adapter protein ankyrin-B in heart <xref ref-type="bibr" rid="pcbi.1000583-Bhasin1">[45]</xref>,<xref ref-type="bibr" rid="pcbi.1000583-Cunha1">[46]</xref>. Furthermore, B56α expression is reduced in cardiomyocytes lacking ankyrin-B <xref ref-type="bibr" rid="pcbi.1000583-Bhasin1">[45]</xref>. More recently, we have shown that expression levels of ankyrin-B are significantly reduced in the BZ leading to altered expression and distribution of ankyrin-B associated membrane proteins including PP2A <xref ref-type="bibr" rid="pcbi.1000583-Hund2">[21]</xref>. Interestingly, previous modeling studies have shown that loss of local phosphatase signaling may greatly potentiate levels of autophosphorylated CaMKII <xref ref-type="bibr" rid="pcbi.1000583-Saucerman1">[27]</xref>. Therefore, loss of ankyrin-B may provide another mechanism for abnormal CaMKII signaling in the BZ through abnormal localization and/or activity of PP2A. Interestingly, patients with ankyrin mutations show catecholaminergic-induced afterdepolarizations <xref ref-type="bibr" rid="pcbi.1000583-Mohler1">[47]</xref>–<xref ref-type="bibr" rid="pcbi.1000583-Mohler2">[49]</xref> as observed in cells with reduced B56α. Future studies are needed to define the upstream signaling pathway(s) responsible for CaMKII activation, Na<sup>+</sup> channel remodeling and increased susceptibility to reentrant arrhythmias after MI.</p>
<p>Finally, it is important to note that activation of CaMKII through direct oxidation has only recently been discovered. Consequently, much remains unknown regarding the signaling mechanisms that regulate this pathway. Analogous to regulation of autophosphorylation by local kinase/phosphatase activity and local concentrations of Ca<sup>2+</sup>/calmodulin, oxidative activation is likely controlled by a delicate balance of oxidase/reductase activity, mitochondrial function and local calcium signaling. Furthermore, degree of crosstalk between oxidative and autophosphorylation pathways and their relative importance in response to the complex set of upstream stressors in heart disease remain to be determined. These details, as they emerge, may be incorporated into our model to analyze the functional consequences of upstream signals that converge through distinct pathways to alter CaMKII activity.</p>
<sec id="s4a">
<title>Limitations</title>
<p>While our mathematical model accounts for central aspects of the newly identified oxidation-dependent pathway for CaMKII activation, it has important limitations based on the available experimental data. Many questions remain to be answered regarding the function of CaMKII oxidation in the normal and diseased heart. For example, how do oxidation and autophosphorylation of CaMKII interact to control regulation of the holoenzyme? Do these pathways interact synergistically to activate the kinase and what are the unique/shared targets for each activation pathway? Finally, what is the relative importance of oxidized versus autophosphorylated CaMKII in normal and diseased hearts? Answers to these questions will not only facilitate the development of more comprehensive models but also will provide critical information necessary to design novel cell-specific therapies for regulating cardiac excitability.</p>
<p>It is important to note that CaMKII in the model detects a subspace pool of Ca<sup>2+</sup> that reaches concentrations somewhere between cytosolic and dyadic concentrations (peak concentration 10–20 µM). Previous modeling studies have shown that the dynamic response of CaMKII may vary greatly between dyadic and cytosolic pools based on variability in concentrations of Ca<sup>2+</sup> and CaM <xref ref-type="bibr" rid="pcbi.1000583-Saucerman1">[27]</xref>. Consistent with previous studies <xref ref-type="bibr" rid="pcbi.1000583-Saucerman1">[27]</xref>, we found that cytosolic Ca<sup>2+</sup> transients do not significantly activate CaMKII activity at baseline or even in the presence of 1 µM H<sub>2</sub>O<sub>2</sub> (&lt;1% maximal activity, not shown). However 10 µM H<sub>2</sub>O<sub>2</sub> was able to activate CaMKII (25% maximal), suggesting that a sufficiently high level of oxidative stress may be able to activate even cytosolic CaMKII. Clearly, local regulation of CaMKII in well-defined subcellular domains is an exciting area for future research with important implications for human disease. As we learn more about CaM and CaMKII signaling in the vicinity of Na<sup>+</sup> channels, it will be important to incorporate these data into the model.</p>
</sec></sec><sec id="s5">
<title>Supporting Information</title>
<supplementary-material id="pcbi.1000583.s001" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000583.s001" xlink:type="simple"><label>Figure S1</label><caption>
<p>Cell excitability as a function of ROS levels in the BZ. (A) Conduction velocity and (B) refractoriness in the infarct BZ as a function of ROS concentration. Conduction velocity is determined across the middle 100 cells in the BZ fiber. Postrepolarization refractoriness is calculated as the difference between effective refractory period and action potential duration at 90% repolarization.</p>
<p>(2.17 MB TIF)</p>
</caption></supplementary-material><supplementary-material id="pcbi.1000583.s002" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000583.s002" xlink:type="simple"><label>Figure S2</label><caption>
<p>Role of autophosphorylation-dependent CaMKII activation in regulating conduction in the infarct BZ. Conduction velocity is determined across the middle 100 cells in the BZ fiber over a range of end diastolic membrane potentials (V<sub>m,dia</sub>). [K<sup>+</sup>]<sub>o</sub> is increased incrementally from 5.4 mM to 13 mM to V<sub>m,dia</sub> from −87 to −63 mV. Elimination of autophosphorylation-dependent CaMKII activation has a small effect on conduction velocity compared to elimination of oxidation-dependent activation.</p>
<p>(2.87 MB TIF)</p>
</caption></supplementary-material><supplementary-material id="pcbi.1000583.s003" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000583.s003" xlink:type="simple"><label>Table S1</label><caption>
<p>Model definitions and abbreviations</p>
<p>(0.02 MB PDF)</p>
</caption></supplementary-material><supplementary-material id="pcbi.1000583.s004" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000583.s004" xlink:type="simple"><label>Table S2</label><caption>
<p>Mathematical model initial conditions</p>
<p>(0.01 MB PDF)</p>
</caption></supplementary-material><supplementary-material id="pcbi.1000583.s005" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000583.s005" xlink:type="simple"><label>Table S3</label><caption>
<p>CaMKII transition rate parameters</p>
<p>(0.01 MB PDF)</p>
</caption></supplementary-material><supplementary-material id="pcbi.1000583.s006" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000583.s006" xlink:type="simple"><label>Text S1</label><caption>
<p>Model equations for NZ and BZ fiber.</p>
<p>(0.06 MB PDF)</p>
</caption></supplementary-material></sec></body>
<back><ref-list>
<title>References</title>
<ref id="pcbi.1000583-Maier1"><label>1</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Maier</surname><given-names>LS</given-names></name>
<name name-style="western"><surname>Bers</surname><given-names>DM</given-names></name>
</person-group>             <year>2002</year>             <article-title>Calcium, calmodulin, and calcium-calmodulin kinase II: heartbeat to heartbeat and beyond.</article-title>             <source>J Mol Cell Cardiol</source>             <volume>34</volume>             <fpage>919</fpage>             <lpage>939</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Anderson1"><label>2</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Anderson</surname><given-names>ME</given-names></name>
</person-group>             <year>2007</year>             <article-title>Multiple downstream proarrhythmic targets for calmodulin kinase II: moving beyond an ion channel-centric focus.</article-title>             <source>Cardiovasc Res</source>             <volume>73</volume>             <fpage>657</fpage>             <lpage>666</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Hoch1"><label>3</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Hoch</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Meyer</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Hetzer</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Krause</surname><given-names>EG</given-names></name>
<name name-style="western"><surname>Karczewski</surname><given-names>P</given-names></name>
</person-group>             <year>1999</year>             <article-title>Identification and expression of delta-isoforms of the multifunctional Ca<sup>2+</sup>/calmodulin-dependent protein kinase in failing and nonfailing human myocardium.</article-title>             <source>Circ Res</source>             <volume>84</volume>             <fpage>713</fpage>             <lpage>721</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Zhang1"><label>4</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Zhang</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Maier</surname><given-names>LS</given-names></name>
<name name-style="western"><surname>Dalton</surname><given-names>ND</given-names></name>
<name name-style="western"><surname>Miyamoto</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Ross</surname><given-names>J</given-names><suffix>Jr</suffix></name>
<etal/></person-group>             <year>2003</year>             <article-title>The delta<sub>C</sub> isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure.</article-title>             <source>Circ Res</source>             <volume>92</volume>             <fpage>912</fpage>             <lpage>919</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Zhang2"><label>5</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Zhang</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Johnson</surname><given-names>EN</given-names></name>
<name name-style="western"><surname>Gu</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Morissette</surname><given-names>MR</given-names></name>
<name name-style="western"><surname>Sah</surname><given-names>VP</given-names></name>
<etal/></person-group>             <year>2002</year>             <article-title>The cardiac-specific nuclear delta<sub>B</sub> isoform of Ca<sup>2+</sup>/calmodulin-dependent protein kinase II induces hypertrophy and dilated cardiomyopathy associated with increased protein phosphatase 2A activity.</article-title>             <source>J Biol Chem</source>             <volume>277</volume>             <fpage>1261</fpage>             <lpage>1267</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Zhang3"><label>6</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Zhang</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Khoo</surname><given-names>MS</given-names></name>
<name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Grueter</surname><given-names>CE</given-names></name>
<etal/></person-group>             <year>2005</year>             <article-title>Calmodulin kinase II inhibition protects against structural heart disease.</article-title>             <source>Nat Med</source>             <volume>11</volume>             <fpage>409</fpage>             <lpage>417</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Backs1"><label>7</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Backs</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Backs</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Neef</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Kreusser</surname><given-names>MM</given-names></name>
<name name-style="western"><surname>Lehmann</surname><given-names>LH</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title>The delta isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload.</article-title>             <source>Proc Natl Acad Sci U S A</source>             <volume>106</volume>             <fpage>2342</fpage>             <lpage>2347</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Ling1"><label>8</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Ling</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Zhang</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Pereira</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Means</surname><given-names>CK</given-names></name>
<name name-style="western"><surname>Cheng</surname><given-names>H</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title>Requirement for Ca<sup>2+</sup>/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice.</article-title>             <source>J Clin Invest</source>             <volume>119</volume>             <fpage>1230</fpage>             <lpage>1240</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Wu1"><label>9</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Temple</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Zhang</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Dzhura</surname><given-names>I</given-names></name>
<name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name>
<etal/></person-group>             <year>2002</year>             <article-title>Calmodulin kinase II and arrhythmias in a mouse model of cardiac hypertrophy.</article-title>             <source>Circulation</source>             <volume>106</volume>             <fpage>1288</fpage>             <lpage>1293</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Khoo1"><label>10</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Khoo</surname><given-names>MS</given-names></name>
<name name-style="western"><surname>Li</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Singh</surname><given-names>MV</given-names></name>
<name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Kannankeril</surname><given-names>P</given-names></name>
<etal/></person-group>             <year>2006</year>             <article-title>Death, cardiac dysfunction, and arrhythmias are increased by calmodulin kinase II in calcineurin cardiomyopathy.</article-title>             <source>Circulation</source>             <volume>114</volume>             <fpage>1352</fpage>             <lpage>1359</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Hudmon1"><label>11</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Hudmon</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Schulman</surname><given-names>H</given-names></name>
</person-group>             <year>2002</year>             <article-title>Structure-function of the multifunctional Ca<sup>2+</sup>/calmodulin-dependent protein kinase II.</article-title>             <source>Biochem J</source>             <volume>364</volume>             <fpage>593</fpage>             <lpage>611</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Erickson1"><label>12</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Erickson</surname><given-names>JR</given-names></name>
<name name-style="western"><surname>Joiner</surname><given-names>ML</given-names></name>
<name name-style="western"><surname>Guan</surname><given-names>X</given-names></name>
<name name-style="western"><surname>Kutschke</surname><given-names>W</given-names></name>
<name name-style="western"><surname>Yang</surname><given-names>J</given-names></name>
<etal/></person-group>             <year>2008</year>             <article-title>A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation.</article-title>             <source>Cell</source>             <volume>133</volume>             <fpage>462</fpage>             <lpage>474</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Xie1"><label>13</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Xie</surname><given-names>LH</given-names></name>
<name name-style="western"><surname>Chen</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Karagueuzian</surname><given-names>HS</given-names></name>
<name name-style="western"><surname>Weiss</surname><given-names>JN</given-names></name>
</person-group>             <year>2009</year>             <article-title>Oxidative-stress-induced afterdepolarizations and calmodulin kinase II signaling.</article-title>             <source>Circ Res</source>             <volume>104</volume>             <fpage>79</fpage>             <lpage>86</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Kinugawa1"><label>14</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Kinugawa</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Tsutsui</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Hayashidani</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Ide</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Suematsu</surname><given-names>N</given-names></name>
<etal/></person-group>             <year>2000</year>             <article-title>Treatment with dimethylthiourea prevents left ventricular remodeling and failure after experimental myocardial infarction in mice: role of oxidative stress.</article-title>             <source>Circ Res</source>             <volume>87</volume>             <fpage>392</fpage>             <lpage>398</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Dillon1"><label>15</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Dillon</surname><given-names>SM</given-names></name>
<name name-style="western"><surname>Allessie</surname><given-names>MA</given-names></name>
<name name-style="western"><surname>Ursell</surname><given-names>PC</given-names></name>
<name name-style="western"><surname>Wit</surname><given-names>AL</given-names></name>
</person-group>             <year>1988</year>             <article-title>Influences of anisotropic tissue structure on reentrant circuits in the epicardial border zone of subacute canine infarcts.</article-title>             <source>Circ Res</source>             <volume>63</volume>             <fpage>182</fpage>             <lpage>206</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-ElSherif1"><label>16</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>El-Sherif</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Hope</surname><given-names>RR</given-names></name>
<name name-style="western"><surname>Scherlag</surname><given-names>BJ</given-names></name>
<name name-style="western"><surname>Lazzara</surname><given-names>R</given-names></name>
</person-group>             <year>1977</year>             <article-title>Re-entrant ventricular arrhythmias in the late myocardial infarction period. 2. Patterns of initiation and termination of re-entry.</article-title>             <source>Circulation</source>             <volume>55</volume>             <fpage>702</fpage>             <lpage>719</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-ElSherif2"><label>17</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>El-Sherif</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Scherlag</surname><given-names>BJ</given-names></name>
<name name-style="western"><surname>Lazzara</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Hope</surname><given-names>RR</given-names></name>
</person-group>             <year>1977</year>             <article-title>Re-entrant ventricular arrhythmias in the late myocardial infarction period. 1. Conduction characteristics in the infarction zone.</article-title>             <source>Circulation</source>             <volume>55</volume>             <fpage>686</fpage>             <lpage>702</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Gough1"><label>18</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Gough</surname><given-names>WB</given-names></name>
<name name-style="western"><surname>Mehra</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Restivo</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Zeiler</surname><given-names>RH</given-names></name>
<name name-style="western"><surname>el-Sherif</surname><given-names>N</given-names></name>
</person-group>             <year>1985</year>             <article-title>Reentrant ventricular arrhythmias in the late myocardial infarction period in the dog. 13. Correlation of activation and refractory maps.</article-title>             <source>Circ Res</source>             <volume>57</volume>             <fpage>432</fpage>             <lpage>442</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Lue1"><label>19</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Lue</surname><given-names>WM</given-names></name>
<name name-style="western"><surname>Boyden</surname><given-names>PA</given-names></name>
</person-group>             <year>1992</year>             <article-title>Abnormal electrical properties of myocytes from chronically infarcted canine heart. Alterations in V<sub>max</sub> and the transient outward current.</article-title>             <source>Circulation</source>             <volume>85</volume>             <fpage>1175</fpage>             <lpage>1188</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Hund1"><label>20</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Hund</surname><given-names>TJ</given-names></name>
<name name-style="western"><surname>Decker</surname><given-names>KF</given-names></name>
<name name-style="western"><surname>Kanter</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Mohler</surname><given-names>PJ</given-names></name>
<name name-style="western"><surname>Boyden</surname><given-names>PA</given-names></name>
<etal/></person-group>             <year>2008</year>             <article-title>Role of activated CaMKII in abnormal calcium homeostasis and I<sub>Na</sub> remodeling after myocardial infarction: Insights from mathematical modeling.</article-title>             <source>J Mol Cell Cardiol</source>             <volume>45</volume>             <fpage>420</fpage>             <lpage>428</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Hund2"><label>21</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Hund</surname><given-names>TJ</given-names></name>
<name name-style="western"><surname>Wright</surname><given-names>PJ</given-names></name>
<name name-style="western"><surname>Dun</surname><given-names>W</given-names></name>
<name name-style="western"><surname>Snyder</surname><given-names>JS</given-names></name>
<name name-style="western"><surname>Boyden</surname><given-names>PA</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title>Regulation of the ankyrin-B-based targeting pathway following myocardial infarction.</article-title>             <source>Cardiovasc Res</source>             <volume>81</volume>             <fpage>742</fpage>             <lpage>749</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Pu1"><label>22</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Pu</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Boyden</surname><given-names>PA</given-names></name>
</person-group>             <year>1997</year>             <article-title>Alterations of Na<sup>+</sup> currents in myocytes from epicardial border zone of the infarcted heart. A possible ionic mechanism for reduced excitability and postrepolarization refractoriness.</article-title>             <source>Circ Res</source>             <volume>81</volume>             <fpage>110</fpage>             <lpage>119</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Shaw1"><label>23</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Shaw</surname><given-names>RM</given-names></name>
<name name-style="western"><surname>Rudy</surname><given-names>Y</given-names></name>
</person-group>             <year>1997</year>             <article-title>Ionic mechanisms of propagation in cardiac tissue. Roles of the sodium and L-type calcium currents during reduced excitability and decreased gap junction coupling.</article-title>             <source>Circ Res</source>             <volume>81</volume>             <fpage>727</fpage>             <lpage>741</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Hund3"><label>24</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Hund</surname><given-names>TJ</given-names></name>
<name name-style="western"><surname>Rudy</surname><given-names>Y</given-names></name>
</person-group>             <year>2004</year>             <article-title>Rate dependence and regulation of action potential and calcium transient in a canine cardiac ventricular cell model.</article-title>             <source>Circulation</source>             <volume>110</volume>             <fpage>3168</fpage>             <lpage>3174</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Hund4"><label>25</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Hund</surname><given-names>TJ</given-names></name>
<name name-style="western"><surname>Kucera</surname><given-names>JP</given-names></name>
<name name-style="western"><surname>Otani</surname><given-names>NF</given-names></name>
<name name-style="western"><surname>Rudy</surname><given-names>Y</given-names></name>
</person-group>             <year>2001</year>             <article-title>Ionic charge conservation and long-term steady state in the Luo-Rudy dynamic model of the cardiac cell.</article-title>             <source>Biophys J</source>             <volume>81</volume>             <fpage>3324</fpage>             <lpage>3331</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Dupont1"><label>26</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Dupont</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Houart</surname><given-names>G</given-names></name>
<name name-style="western"><surname>De Koninck</surname><given-names>P</given-names></name>
</person-group>             <year>2003</year>             <article-title>Sensitivity of CaM kinase II to the frequency of Ca<sup>2+</sup> oscillations: a simple model.</article-title>             <source>Cell Calcium</source>             <volume>34</volume>             <fpage>485</fpage>             <lpage>497</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Saucerman1"><label>27</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Saucerman</surname><given-names>JJ</given-names></name>
<name name-style="western"><surname>Bers</surname><given-names>DM</given-names></name>
</person-group>             <year>2008</year>             <article-title>Calmodulin mediates differential sensitivity of CaMKII and calcineurin to local Ca<sup>2+</sup> in cardiac myocytes.</article-title>             <source>Biophys J</source>             <volume>95</volume>             <fpage>4597</fpage>             <lpage>4612</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Hashambhoy1"><label>28</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Hashambhoy</surname><given-names>YL</given-names></name>
<name name-style="western"><surname>Winslow</surname><given-names>RL</given-names></name>
<name name-style="western"><surname>Greenstein</surname><given-names>JL</given-names></name>
</person-group>             <year>2009</year>             <article-title>CaMKII-induced shift in modal gating explains L-type Ca<sup>2+</sup> current facilitation: a modeling study.</article-title>             <source>Biophys J</source>             <volume>96</volume>             <fpage>1770</fpage>             <lpage>1785</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Frei1"><label>29</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Frei</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Yamamoto</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Niclas</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Ames</surname><given-names>BN</given-names></name>
</person-group>             <year>1988</year>             <article-title>Evaluation of an isoluminol chemiluminescence assay for the detection of hydroperoxides in human blood plasma.</article-title>             <source>Anal Biochem</source>             <volume>175</volume>             <fpage>120</fpage>             <lpage>130</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Halliwell1"><label>30</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Halliwell</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Clement</surname><given-names>MV</given-names></name>
<name name-style="western"><surname>Long</surname><given-names>LH</given-names></name>
</person-group>             <year>2000</year>             <article-title>Hydrogen peroxide in the human body.</article-title>             <source>FEBS Lett</source>             <volume>486</volume>             <fpage>10</fpage>             <lpage>13</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Slezak1"><label>31</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Slezak</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Tribulova</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Pristacova</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Uhrik</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Thomas</surname><given-names>T</given-names></name>
<etal/></person-group>             <year>1995</year>             <article-title>Hydrogen peroxide changes in ischemic and reperfused heart. Cytochemistry and biochemical and X-ray microanalysis.</article-title>             <source>Am J Pathol</source>             <volume>147</volume>             <fpage>772</fpage>             <lpage>781</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Zweier1"><label>32</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Zweier</surname><given-names>JL</given-names></name>
<name name-style="western"><surname>Flaherty</surname><given-names>JT</given-names></name>
<name name-style="western"><surname>Weisfeldt</surname><given-names>ML</given-names></name>
</person-group>             <year>1987</year>             <article-title>Direct measurement of free radical generation following reperfusion of ischemic myocardium.</article-title>             <source>Proc Natl Acad Sci U S A</source>             <volume>84</volume>             <fpage>1404</fpage>             <lpage>1407</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Dhalla1"><label>33</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Dhalla</surname><given-names>NS</given-names></name>
<name name-style="western"><surname>Duhamel</surname><given-names>TA</given-names></name>
</person-group>             <year>2007</year>             <article-title>The paradoxes of reperfusion in the ischemic heart.</article-title>             <source>Heart Metab</source>             <volume>37</volume>             <fpage>31</fpage>             <lpage>34</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Fukuda1"><label>34</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Fukuda</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Davies</surname><given-names>SS</given-names></name>
<name name-style="western"><surname>Nakajima</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Ong</surname><given-names>BH</given-names></name>
<name name-style="western"><surname>Kupershmidt</surname><given-names>S</given-names></name>
<etal/></person-group>             <year>2005</year>             <article-title>Oxidative mediated lipid peroxidation recapitulates proarrhythmic effects on cardiac sodium channels.</article-title>             <source>Circ Res</source>             <volume>97</volume>             <fpage>1262</fpage>             <lpage>1269</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Ursell1"><label>35</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Ursell</surname><given-names>PC</given-names></name>
<name name-style="western"><surname>Gardner</surname><given-names>PI</given-names></name>
<name name-style="western"><surname>Albala</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Fenoglio</surname><given-names>JJ</given-names><suffix>Jr</suffix></name>
<name name-style="western"><surname>Wit</surname><given-names>AL</given-names></name>
</person-group>             <year>1985</year>             <article-title>Structural and electrophysiological changes in the epicardial border zone of canine myocardial infarcts during infarct healing.</article-title>             <source>Circ Res</source>             <volume>56</volume>             <fpage>436</fpage>             <lpage>451</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Lau1"><label>36</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Lau</surname><given-names>DH</given-names></name>
<name name-style="western"><surname>Clausen</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Sosunov</surname><given-names>EA</given-names></name>
<name name-style="western"><surname>Shlapakova</surname><given-names>IN</given-names></name>
<name name-style="western"><surname>Anyukhovsky</surname><given-names>EP</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title>Epicardial border zone overexpression of skeletal muscle sodium channel SkM1 normalizes activation, preserves conduction, and suppresses ventricular arrhythmia: an in silico, in vivo, in vitro study.</article-title>             <source>Circulation</source>             <volume>119</volume>             <fpage>19</fpage>             <lpage>27</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Cabo1"><label>37</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Cabo</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Yao</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Boyden</surname><given-names>PA</given-names></name>
<name name-style="western"><surname>Chen</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Hussain</surname><given-names>W</given-names></name>
<etal/></person-group>             <year>2006</year>             <article-title>Heterogeneous gap junction remodeling in reentrant circuits in the epicardial border zone of the healing canine infarct.</article-title>             <source>Cardiovasc Res</source>             <volume>72</volume>             <fpage>241</fpage>             <lpage>249</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Peters1"><label>38</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Peters</surname><given-names>NS</given-names></name>
<name name-style="western"><surname>Coromilas</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Severs</surname><given-names>NJ</given-names></name>
<name name-style="western"><surname>Wit</surname><given-names>AL</given-names></name>
</person-group>             <year>1997</year>             <article-title>Disturbed connexin43 gap junction distribution correlates with the location of reentrant circuits in the epicardial border zone of healing canine infarcts that cause ventricular tachycardia.</article-title>             <source>Circulation</source>             <volume>95</volume>             <fpage>988</fpage>             <lpage>996</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Cabo2"><label>39</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Cabo</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Boyden</surname><given-names>P</given-names></name>
</person-group>             <year>2003</year>             <article-title>Electrical remodeling of the epicardial border zone in the canine infarcted heart: a computational analysis.</article-title>             <source>Am J Physiol Heart Circ Physiol</source>             <volume>284</volume>             <fpage>H372</fpage>             <lpage>H384</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Starmer1"><label>40</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Starmer</surname><given-names>CF</given-names></name>
<name name-style="western"><surname>Colatsky</surname><given-names>TJ</given-names></name>
<name name-style="western"><surname>Grant</surname><given-names>AO</given-names></name>
</person-group>             <year>2003</year>             <article-title>What happens when cardiac Na channels lose their function? 1–numerical studies of the vulnerable period in tissue expressing mutant channels.</article-title>             <source>Cardiovasc Res</source>             <volume>57</volume>             <fpage>82</fpage>             <lpage>91</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Wagner1"><label>41</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Wagner</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Dybkova</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Rasenack</surname><given-names>EC</given-names></name>
<name name-style="western"><surname>Jacobshagen</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Fabritz</surname><given-names>L</given-names></name>
<etal/></person-group>             <year>2006</year>             <article-title>Ca/calmodulin-dependent protein kinase II regulates cardiac Na channels.</article-title>             <source>J Clin Invest</source>             <volume>116</volume>             <fpage>3127</fpage>             <lpage>3138</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Cabo3"><label>42</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Cabo</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Boyden</surname><given-names>PA</given-names></name>
</person-group>             <year>2009</year>             <article-title>Extracellular space attenuates the effect of gap junctional remodeling on wave propagation: a computational study.</article-title>             <source>Biophys J</source>             <volume>96</volume>             <fpage>3092</fpage>             <lpage>3101</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Giordano1"><label>43</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Giordano</surname><given-names>FJ</given-names></name>
</person-group>             <year>2005</year>             <article-title>Oxygen, oxidative stress, hypoxia, and heart failure.</article-title>             <source>J Clin Invest</source>             <volume>115</volume>             <fpage>500</fpage>             <lpage>508</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Terentyev1"><label>44</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Terentyev</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Belevych</surname><given-names>AE</given-names></name>
<name name-style="western"><surname>Terentyeva</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Martin</surname><given-names>MM</given-names></name>
<name name-style="western"><surname>Malana</surname><given-names>GE</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title>miR-1 overexpression enhances Ca<sup>2+</sup> release and promotes cardiac arrhythmogenesis by targeting PP2A regulatory subunit B56alpha and causing CaMKII-dependent hyperphosphorylation of RyR2.</article-title>             <source>Circ Res</source>             <volume>104</volume>             <fpage>514</fpage>             <lpage>521</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Bhasin1"><label>45</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Bhasin</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Cunha</surname><given-names>SR</given-names></name>
<name name-style="western"><surname>Mduannayake</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Gigena</surname><given-names>MS</given-names></name>
<name name-style="western"><surname>Rogers</surname><given-names>TB</given-names></name>
<etal/></person-group>             <year>2007</year>             <article-title>Molecular basis for PP2A regulatory subunit B56 alpha targeting in cardiomyocytes.</article-title>             <source>Am J Physiol Heart Circ Physiol</source>             <volume>293</volume>             <fpage>H109</fpage>             <lpage>119</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Cunha1"><label>46</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Cunha</surname><given-names>SR</given-names></name>
<name name-style="western"><surname>Mohler</surname><given-names>PJ</given-names></name>
</person-group>             <year>2008</year>             <article-title>Obscurin targets ankyrin-B and protein phosphatase 2A to the cardiac M-line.</article-title>             <source>J Biol Chem</source>             <volume>283</volume>             <fpage>31968</fpage>             <lpage>31980</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Mohler1"><label>47</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Mohler</surname><given-names>PJ</given-names></name>
<name name-style="western"><surname>Splawski</surname><given-names>I</given-names></name>
<name name-style="western"><surname>Napolitano</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Bottelli</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Sharpe</surname><given-names>L</given-names></name>
<etal/></person-group>             <year>2004</year>             <article-title>A cardiac arrhythmia syndrome caused by loss of ankyrin-B function.</article-title>             <source>Proc Natl Acad Sci U S A</source>             <volume>101</volume>             <fpage>9137</fpage>             <lpage>9142</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Schott1"><label>48</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Schott</surname><given-names>JJ</given-names></name>
<name name-style="western"><surname>Charpentier</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Peltier</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Foley</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Drouin</surname><given-names>E</given-names></name>
<etal/></person-group>             <year>1995</year>             <article-title>Mapping of a gene for long QT syndrome to chromosome 4q25-27.</article-title>             <source>Am J Hum Genet</source>             <volume>57</volume>             <fpage>1114</fpage>             <lpage>1122</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Mohler2"><label>49</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Mohler</surname><given-names>PJ</given-names></name>
<name name-style="western"><surname>Schott</surname><given-names>JJ</given-names></name>
<name name-style="western"><surname>Gramolini</surname><given-names>AO</given-names></name>
<name name-style="western"><surname>Dilly</surname><given-names>KW</given-names></name>
<name name-style="western"><surname>Guatimosim</surname><given-names>S</given-names></name>
<etal/></person-group>             <year>2003</year>             <article-title>Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death.</article-title>             <source>Nature</source>             <volume>421</volume>             <fpage>634</fpage>             <lpage>639</lpage>          </element-citation></ref>
<ref id="pcbi.1000583-Gaertner1"><label>50</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Gaertner</surname><given-names>TR</given-names></name>
<name name-style="western"><surname>Kolodziej</surname><given-names>SJ</given-names></name>
<name name-style="western"><surname>Wang</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Kobayashi</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Koomen</surname><given-names>JM</given-names></name>
<etal/></person-group>             <year>2004</year>             <article-title>Comparative analyses of the three-dimensional structures and enzymatic properties of alpha, beta, gamma and delta isoforms of Ca<sup>2+</sup>-calmodulin-dependent protein kinase II.</article-title>             <source>J Biol Chem</source>             <volume>279</volume>             <fpage>12484</fpage>             <lpage>12494</lpage>          </element-citation></ref>
</ref-list>

</back>
</article>